These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6602778)

  • 1. Antilymphoma graft responses in the mouse brain: a study of T-dependent functions.
    Puccetti P; Giampietri A; Campanile F; Romani L; Fioretti MC
    Int J Cancer; 1983 Jun; 31(6):769-74. PubMed ID: 6602778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies.
    Bonmassar A; Riccardi C; Rivosecchi-Merletti P; Goldin A; Bonmassar E
    Int J Cancer; 1980 Dec; 26(6):819-29. PubMed ID: 6971268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression of antilymphoma allograft reactivity by tumor-associated factors.
    Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
    Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
    Yamasaki T; Moritake K; Klein G
    J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigens acting as helper determinants for tumor-associated antigens of murine lymphosarcoma.
    Colnaghi MI
    Eur J Immunol; 1975 Apr; 5(4):241-5. PubMed ID: 1086228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response in the mouse brain: I. Transplantation immunity to mouse lymphoma graft.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):191-201. PubMed ID: 3248016
    [No Abstract]   [Full Text] [Related]  

  • 8. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses.
    Mundhada S; Shaw J; Mori S; Savary CA; Mullen CA
    Leuk Lymphoma; 2005 Apr; 46(4):571-80. PubMed ID: 16019486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for virus-specific transplantation antigen in cells of lymphoid neoplasms induced by papovavirus SV40.
    Tevethia SS
    Int J Cancer; 1974 Apr; 13(4):494-9. PubMed ID: 4135417
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenetic aspects of transplantation in the rat brain.
    Geyer SJ; Gill TJ; Kunz HW; Moody E
    Transplantation; 1985 Mar; 39(3):244-7. PubMed ID: 3883588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunization and graft versus host reactions.
    Datta SK; Schwartz RS
    Transplant Rev; 1976; 31():44-78. PubMed ID: 8861
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of host antitumor immune responses and chemotherapy. Studies with hexamethylmelamine.
    Tricarico M; Fuschiotti P; Ricci F; De Filippi R; Nunziata C; Pastore S; De Vecchis L
    Chemioterapia; 1988 Jun; 7(3):203-7. PubMed ID: 3139307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT; Herberman RB
    Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
    [No Abstract]   [Full Text] [Related]  

  • 16. Mouse brain: an immunologically privileged site for natural resistance against lymphoma cells.
    Circolo A; Bianchi R; Nardelli B; Rivosecchi-Merletti P; Bonmassar E
    J Immunol; 1982 Feb; 128(2):556-62. PubMed ID: 7054288
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic tumor-syngeneic muscle sandwich grafts: a method for promoting nonspecific growth.
    Parks RC
    J Natl Cancer Inst; 1976 Jun; 56(6):1281-4. PubMed ID: 994227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of antineoplastic agents and anti-lymphoma allograft reactions.
    Riccardi C; Bartocci A; Puccetti P; Spreafico F; Bonmassar E; Goldin A
    Eur J Cancer (1965); 1980 Jan; 16(1):23-33. PubMed ID: 7358077
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological response in the mouse brain: II. Experimental immunotherapy model against transplanted mouse lymphoma in the brain.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):202-14. PubMed ID: 3266837
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
    Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
    No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.